miR-485-3p在消化系统肿瘤中的研究进展
Research Progress of miR-485-3p in Digestive System Tumors
DOI: 10.12677/acm.2024.143968, PDF,   
作者: 孙家浩, 李 杰:山东大学齐鲁医学院,山东 济南;孙文胜:临沂市中心医院普外科,山东 临沂
关键词: miR-485-3p肿瘤细胞增殖miR-485-3p Tumor Cell Proliferation
摘要: microRNAs (miRNAs)是一类在动物、植物、病毒进化上保守的非编码RNA,并已被证明通过转录后调节发挥作用,参与多种生物学过程。最近的研究表明,miRNAs可调节基因组不稳定性,尤其在许多癌症中,miRNA的表达失调会导致肿瘤异质性和耐药性的基因改变。因此,近几年来miRNA在肿瘤中的作用是研究热点之一,miR-485-3P便是其中之一。现有研究表明,miR-485-3P可通过调控PD-L1、JAK2、STAT3、MAT1A等明星分子来改变细胞凋亡、增殖、迁移等生物学功能,从而调控结直肠癌、肝细胞癌、胃癌、胰腺癌等恶性肿瘤进展,同时也参与了其他肿瘤的调控。在本篇综述中,我们主要概述了目前关于miR-485-3p在消化系统肿瘤中的调控机制的相关研究进展。期望我们的工作可以为上述肿瘤的进一步研究带来益处。
Abstract: microRNAs (miRNAs) are a class of non-coding RNAs that are conserved in the evolution of animals, plants, and viruses, and have been shown to play a role through post-transcriptional regulation and participate in a variety of biological processes. Recent studies have shown that miRNAs can regulate genomic instability, especially in many cancers, and dysregulation of miRNA expression can lead to genetic changes in tumor heterogeneity and drug resistance. Therefore, in recent years, the role of miRNAs in tumors has been one of the research hotspots, and miR-485-3P is one of them. Previous studies have shown that miR-485-3P can change the biological functions of apoptosis, proliferation and migration by regulating PD-L1, JAK2, STAT3, MAT1A and other star molecules, so as to regulate the progression of malignant tumors such as colorectal cancer, hepatocellular carcinoma, gastric cancer, pancreatic cancer, etc., and also participate in the regulation of other tumors. In this review, we mainly summarize the current research progress on the regulatory mechanism of miR-485-3p in digestive system tumors. It is expected that our work can bring benefits to the further study of the above tumors.
文章引用:孙家浩, 孙文胜, 李杰. miR-485-3p在消化系统肿瘤中的研究进展[J]. 临床医学进展, 2024, 14(3): 2240-2246. https://doi.org/10.12677/acm.2024.143968

参考文献

[1] Yates, L.A., Norbury, C.J. and Gilbert, R.J. (2013) The Long and Short of microRNA. Cell, 153, 516-519. [Google Scholar] [CrossRef] [PubMed]
[2] Towler, B.P., Jones, C.I. and Newbury, S.F. (2015) Mechanisms of Regulation of Mature miRNAs. Biochemical Society Transactions, 43, 1208-1214. [Google Scholar] [CrossRef
[3] Xiao, M., Li, J., Li, W., et al. (2017) microRNAs Activate Gene Transcription Epigenetically as an Enhancer Trigger. RNA Biology, 14, 1326-1334. [Google Scholar] [CrossRef] [PubMed]
[4] Suzuki, H.I., Young, R.A. and Sharp, P.A. (2017) Super-Enhancer-Mediated RNA Processing Revealed by Integrative microRNA Network Analysis. Cell, 168, 1000-1014.E15. [Google Scholar] [CrossRef] [PubMed]
[5] Ferragut Cardoso, A.P., Banerjee, M., Nail, A.N., et al. (2021) miRNA Dysregulation Is an Emerging Modulator of Genomic Instability. Seminars in Cancer Biology, 76, 120-131. [Google Scholar] [CrossRef] [PubMed]
[6] Alipourgivi, F., Motolani, A., Qiu, A.Y., et al. (2023) Genetic Alterations of NF-κB and Its Regulators: A Rich Platform to Advance Colorectal Cancer Diagnosis and Treatment. International Journal of Molecular Sciences, 25, Article No. 154. [Google Scholar] [CrossRef] [PubMed]
[7] Wang, S., Xu, B., Zhang, Y., et al. (2023) The Role of Intestinal Flora on Tumorigenesis, Progression, and the Efficacy of PD-1/PD-L1 Antibodies in Colorectal Cancer. Cancer Biology & Medicine, 2023, Article ID: 20230376. [Google Scholar] [CrossRef] [PubMed]
[8] Han, J.H., Lee, E.J., Park, W., et al. (2023) Cosmosiin Induces Apoptosis in Colorectal Cancer by Inhibiting PD-L1 Expression and Inducing ROS. Antioxidants (Basel, Switzerland), 12, Article No. 2131. [Google Scholar] [CrossRef] [PubMed]
[9] Glorieux, C., Xia, X., He, Y.Q., et al. (2021) Regulation of PD-L1 Expression in K-Ras-Driven Cancers through ROS-Mediated FGFR1 Signaling. Redox Biology, 38, Article ID: 101780. [Google Scholar] [CrossRef] [PubMed]
[10] Jiang, Z., Hou, Z., Liu, W., et al. (2021) circ-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 Axis. The Journal of Pharmacology and Experimental Therapeutics, 377, 358-367. [Google Scholar] [CrossRef] [PubMed]
[11] Huang, B., Lang, X. and Li, X. (2022) The Role of IL-6/JAK2/STAT3 Signaling Pathway in Cancers. Frontiers in Oncology, 12, Article ID: 1023177. [Google Scholar] [CrossRef] [PubMed]
[12] Schulz-Heddergott, R., Stark, N., Edmunds, S.J., et al. (2018) Therapeutic Ablation of Gain-of-Function Mutant P53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion. Cancer Cell, 34, 298-314.E7. [Google Scholar] [CrossRef] [PubMed]
[13] Wei, C., Yang, C., Wang, S., et al. (2019) Crosstalk between Cancer Cells and Tumor Associated Macrophages Is Required for Mesenchymal circulating Tumor Cell-Mediated Colorectal Cancer Metastasis. Molecular Cancer, 18, Article No. 64. [Google Scholar] [CrossRef] [PubMed]
[14] Li, Y., Shi, Y., Zhang, X., et al. (2023) FGFR2 Upregulates PAI-1 via JAK2/STAT3 Signaling to Induce M2 Polarization of Macrophages in Colorectal Cancer. Biochimica et Biophysica Acta Molecular Basis of Disease, 1869, Article ID: 166665. [Google Scholar] [CrossRef] [PubMed]
[15] Wang, J., Zhang, Y., Song, H., et al. (2021) The circular RNA circSPARC Enhances the Migration and Proliferation of Colorectal Cancer by Regulating the JAK/STAT Pathway. Molecular Cancer, 20, Article No. 81. [Google Scholar] [CrossRef] [PubMed]
[16] Zhao, K., Cheng, X., Ye, Z., et al. (2023) Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating microRNA 217 (miR-217) and miR-485-3p. Molecular and Cellular Biology, 41, e00517-20. [Google Scholar] [CrossRef
[17] Su, S., Lu, W., Liu, J., et al. (2021) circ_0007031 Silencing Inhibits Cell Proliferation and Induces Cell Apoptosis via Downregulating MELK at a miR-485-3p-Dependent Way in Colorectal Cancer. Biochemical Genetics, 60, 576-597. [Google Scholar] [CrossRef] [PubMed]
[18] Ying, J., Liu, G. and Zhu, X. (2023) miR-485-3p/miR-543/miR-337-3p Is Required for the Oncogenic Potential of the Hsa_circ_0007385-MEMO1 Axis in Colorectal Cancer. Biochemical Genetics. [Google Scholar] [CrossRef] [PubMed]
[19] Li, Y.J., Qiu, Y.L., Li, M.R., et al. (2024) New Horizons for the Role of RNA N6-Methyladenosine Modification in Hepatocellular Carcinoma. Acta Pharmacologica Sinica. [Google Scholar] [CrossRef] [PubMed]
[20] Fan, W., Cao, D., Yang, B., et al. (2023) Hepatic Prohibitin 1 and Methionine Adenosyltransferase α1 Defend against Primary and Secondary Liver Cancer Metastasis. Journal of Hepatology, 80, 443-453. [Google Scholar] [CrossRef] [PubMed]
[21] Vázquez-Chantada, M., Fernández-Ramos, D., Embade, N., et al. (2010) HuR/Methyl-HuR and AUF1 Regulate the MAT Expressed during Liver Proliferation, Differentiation, and Carcinogenesis. Gastroenterology, 138, 1943-1953. [Google Scholar] [CrossRef] [PubMed]
[22] Xiong, D., Sheng, Y., Ding, S., et al. (2016) LINC00052 Regulates the Expression of NTRK3 by miR-128 and miR-485-3p to Strengthen HCC Cells Invasion and Migration. Oncotarget, 7, 47593-47608. [Google Scholar] [CrossRef] [PubMed]
[23] Stosic, K., Senar, O.A., Tarfouss, J., et al. (2023) A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma. Cells, 13, Article No. 3. [Google Scholar] [CrossRef] [PubMed]
[24] Gautam, S.K., Batra, S.K. and Jain, M. (2023) Molecular and Metabolic Regulation of Immunosuppression in Metastatic Pancreatic Ductal Adenocarcinoma. Molecular Cancer, 22, Article No. 118. [Google Scholar] [CrossRef] [PubMed]
[25] Pal, A., Ojha, A. and Ju, J. (2023) Functional and Potential Therapeutic Implication of microRNAs in Pancreatic Cancer. International Journal of Molecular Sciences, 24, Article No. 17523. [Google Scholar] [CrossRef] [PubMed]
[26] Li, M., Zhou, J., Zhang, Z., et al. (2022) Exosomal miR-485-3p Derived from Pancreatic Ductal Epithelial Cells Inhibits Pancreatic Cancer Metastasis through Targeting PAK1. Chinese Medical Journal, 135, 2326-2337. [Google Scholar] [CrossRef
[27] Matsuoka, T. and Yashiro, M. (2023) Molecular Insight into Gastric Cancer Invasion—Current Status and Future Directions. Cancers, 16, Article No. 54. [Google Scholar] [CrossRef] [PubMed]
[28] Wang, H., Wang, N., Zheng, X., et al. (2021) circular RNA hsa_circ_0009172 Suppresses Gastric Cancer by Regulation of microRNA-485-3p-Mediated NTRK3. Cancer Gene Therapy, 28, 1312-1324. [Google Scholar] [CrossRef] [PubMed]
[29] Wang, Z., Wang, Q., Chen, C., et al. (2023) NNMT Enriches for AQP5( ) Cancer Stem Cells to Drive Malignant Progression in Early Gastric Cardia Adenocarcinoma. Gut, 73, 63-77. [Google Scholar] [CrossRef] [PubMed]
[30] Tan, P. and Chu, Y. (2023) Single-Cell Profiling of Gastric Cardia Adenocarcinoma Reveals Drivers of Cancer Stemness and Therapeutic Targets. Gut, 73, 1-2. [Google Scholar] [CrossRef] [PubMed]
[31] Wang, J., Zhang, H., Zhou, X., et al. (2018) Five Serum-Based miRNAs Were Identified as Potential Diagnostic Biomarkers in Gastric Cardia Adenocarcinoma. Cancer Biomarkers, 23, 193-203. [Google Scholar] [CrossRef
[32] Jia, N., Tong, H., Zhang, Y., et al. (2019) CeRNA Expression Profiling Identifies KIT-Related circRNA-miRNA-mRNA Networks in Gastrointestinal Stromal Tumour. Frontiers in Genetics, 10, Article No. 825. [Google Scholar] [CrossRef] [PubMed]